[{"begin": 0, "end": 63, "text": "Cheah CY, Nastoupil LJ, Neelapu SS, Forbes SG, Oki Y, Fowler NH", "tokenized_text": "Cheah CY , Nastoupil LJ , Neelapu SS , Forbes SG , Oki Y , Fowler NH", "type": "authors", "id": 0}, {"begin": 65, "end": 77, "text": "Lenalidomide", "tokenized_text": "Lenalidomide", "type": "title", "id": 1}, {"begin": 79, "end": 182, "text": "idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma", "tokenized_text": "idelalisib , and rituximab are unacceptably toxic in patients with relapsed / refractory indolent lymphoma", "type": "title", "id": 2}, {"begin": 184, "end": 189, "text": "Blood", "tokenized_text": "Blood", "type": "venue", "id": 3}, {"begin": 191, "end": 195, "text": "2015", "tokenized_text": "2015", "type": "year", "id": 4}]